Feline Liver Disease Welfare and Management

Liver disease in cats encompasses several conditions from hepatic lipidosis to cholangitis, causing significant welfare impact and requiring early veterinary intervention.

Key Facts

Hepatic lipidosis (fatty liver syndrome) is uniquely common in cats compared to other species
Any period of anorexia lasting more than 48-72 hours can trigger hepatic lipidosis in obese cats
Inflammatory liver disease (cholangitis) is the most common liver condition in cats
Liver disease causes nausea, jaundice, reduced appetite, and neurological signs (hepatic encephalopathy)
Placement of a feeding tube is often required for nutritional support during hepatic lipidosis treatment

Welfare Considerations

Feline liver disease causes significant suffering through nausea, malaise, and in severe cases neurological dysfunction. Hepatic lipidosis is a particular welfare concern because it is triggered by any cause of reduced food intake, creating a vicious cycle where nausea reduces eating, which worsens lipidosis. Early recognition of anorexia and immediate veterinary intervention prevents the development of severe hepatic lipidosis. Nutritional support through feeding tube placement is welfare-positive as it restores nutrition while allowing the liver to recover. Obese cats are at significantly higher risk and weight management is the most important prevention strategy. Cholangitis requires antibiotic and immunosuppressive treatment and carries welfare impact from both the disease and its treatment.

What You Can Do

Seek veterinary attention for any cat that has not eaten for more than 48 hours
Manage cat body weight proactively to reduce hepatic lipidosis risk in obese cats
Follow veterinary guidance on feeding tube management for cats with severe hepatic lipidosis
Monitor cats with known liver disease with regular blood work to guide treatment adjustments